The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimize BB/ivabradine dosage, as compared to a prior historical control.
Cardiomyopathies, Heart Failure
The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimize BB/ivabradine dosage, as compared to a prior historical control.
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
-
TriHealth Hatton Research Institute, Cincinnati, Ohio, United States, 45242
Texas Cardiology Associates of Houston, Kingwood, Texas, United States, 77339
CardioVoyage, McKinney, Texas, United States, 75020
CAMC, Charleston, West Virginia, United States, 25304
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
FEMALE
No
Zoll Medical Corporation,
Valentina Kutyifa, MD PHD, PRINCIPAL_INVESTIGATOR, University of Rochester
2024-12